Investing in Newron Pharmaceuticals (VTX:NWRN) three years ago would have delivered you a 294% gain

By Yahoo! Finance | Oct 8, 2024 at 03:06 AM EST

Newron Pharmaceuticals' stock price has surged 294% in three years, with revenue growing at 16% annually. While the company isn't profitable yet, the market shows optimism. Shareholders received a 28% return in one year, indicating improved performance.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.